The portfolio maintains a cost advantage over competitors, priced within the cheapest fee quintile among peers.
iShares Neuroscience and Healthcare ETF IBRN ETF Analysis
Morningstar’s Analysis IBRN
Will IBRN outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar